MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

Nastech Pharmaceutical Company

Nasal drug delivery company.

The company in detail

Summary

Nastech Pharmaceutical Company was incorporated in 1983, as a formulation science company concerning nasal drug delivery technology. The company completed a public offering of shares of common stock on the NASDAQ in 1997 and acquired Atossa HealthCare in 2000. Nastech's business strategy seeks to broaden applications of its commitment to Formulation Science, allowing drugs to be more safe and effective in patient treatment, with particular emphasis on the applications for nasal or oral drug delivery in the prescription and over-the-counter markets. The company focuses its research and development activities on injectable drugs with demonstrated safety and efficacy, and with an unaddressed market need, in order to enter into early stage collaborative alliances with major pharmaceutical companies and bring to market new, improved therapies that may expand the market for certain drugs. Using Formulation Science, Nastech seeks to establish domestic and international relationships with major pharmaceutical companies for the early stage introduction of nasal or oral dosage forms of drug delivery as a viable alternative to injectable therapy. With this approach Nastech would devote its resources to the further development of its technology while leveraging the established product development, sales and marketing capabilities of its collaborative partners in significant markets. Nastech has one registered subsidiary Atossa HealthCare.

R&D

To view this information, you must subscribe to PL Intelligence.

Partnerships

To view this information, you must subscribe to PL Intelligence.

Deals

To view this information, you must subscribe to PL Intelligence.

Senior management

To view this information, you must subscribe to PL Intelligence.

Board of directors

To view this information, you must subscribe to PL Intelligence.

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us